Previous Article | Next Article 
Journal of Virology, October 2001, p. 9828-9835, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9828-9835.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Contribution of Vascular Endothelial Growth Factor
in the Neovascularization Process during the Pathogenesis of
Herpetic Stromal Keratitis
Mei
Zheng,1
Shilpa
Deshpande,1
Sujin
Lee,1
Napoleone
Ferrara,2 and
Barry T.
Rouse1,*
Department of Microbiology, University of
Tennessee, Knoxville, Tennessee 37996,1 and
Department of Molecular Oncology, Genentech Incorporated,
South San Francisco, California 940802
Received 21 May 2001/Accepted 12 July 2001
This report analyzes the role of vascular endothelial growth factor
(VEGF)-induced angiogenesis in the immunoinflammatory lesion stromal
keratitis induced by ocular infection with herpes simplex virus (HSV).
Our results show that infection with replication-competent, but not
mutant, viruses results in the expression of VEGF mRNA and protein in
the cornea. This a rapid event, with VEGF mRNA detectable by 12 h
postinfection (p.i.) and proteins detectable by 24 h p.i. VEGF
production occurred both in the virus-infected corneal epithelium and
in the underlying stroma, in which viral antigens were undetectable. In
the stroma, VEGF was produced by inflammatory cells; these initially
were predominantly polymorphonuclear leukocytes (PMN), but at later
time points both PMN and macrophage-like cells were VEGF producers. In
the epithelium, the major site of VEGF-expressing cells in early
infection, the infected cells themselves were usually negative for
VEGF. Similarly, in vitro infection studies indicated that the cells
which produced VEGF were not those which expressed virus. Attesting to
the possible role of VEGF-induced angiogenesis in the pathogenesis of
herpetic stromal keratitis were experiments showing that VEGF
inhibition with mFlt(1-3)-immunoglobulin G diminished angiogenesis and
the severity of lesions after HSV infection. These observations are the
first to evaluate VEGF-induced angiogenesis in the pathogenesis of
stromal keratitis. Our results indicate that the control of
angiogenesis represents a useful adjunct to therapy of herpetic ocular
disease, an important cause of human blindness.
*
Corresponding author. Mailing address: Dept. of
Microbiology, M409 Walters Life Sciences Building, The University of
Tennessee, 1414 Cumberland Ave., Knoxville, TN 37996. Phone: (865)
974-4026. Fax: (865) 974-4007. E-mail: btr{at}utk.edu.
Journal of Virology, October 2001, p. 9828-9835, Vol. 75, No. 20
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.20.9828-9835.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zheng, M., Fields, M. A., Liu, Y., Cathcart, H., Richter, E., Atherton, S. S.
(2008). Neutrophils Protect the Retina of the Injected Eye from Infection after Anterior Chamber Inoculation of HSV-1 in BALB/c Mice. IOVS
49: 4018-4025
[Abstract]
[Full Text]
-
Divito, S. J., Hendricks, R. L.
(2008). Activated Inflammatory Infiltrate in HSV-1-Infected Corneas without Herpes Stromal Keratitis. IOVS
49: 1488-1495
[Abstract]
[Full Text]
-
Yu, L., Wu, X., Cheng, Z., Lee, C. V., LeCouter, J., Campa, C., Fuh, G., Lowman, H., Ferrara, N.
(2008). Interaction between Bevacizumab and Murine VEGF-A: A Reassessment. IOVS
49: 522-527
[Abstract]
[Full Text]
-
Sarangi, P. P., Kim, B., Kurt-Jones, E., Rouse, B. T.
(2007). Innate Recognition Network Driving Herpes Simplex Virus-Induced Corneal Immunopathology: Role of the Toll Pathway in Early Inflammatory Events in Stromal Keratitis. J. Virol.
81: 11128-11138
[Abstract]
[Full Text]
-
Manzano, R. P A, Peyman, G. A, Khan, P., Carvounis, P. E, Kivilcim, M., Ren, M., Lake, J. C, Chevez-Barrios, P.
(2007). Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin). Br J Ophthalmol
91: 804-807
[Abstract]
[Full Text]
-
Aghi, M., Rabkin, S. D., Martuza, R. L.
(2007). Angiogenic Response Caused by Oncolytic Herpes Simplex Virus-Induced Reduced Thrombospondin Expression Can Be Prevented by Specific Viral Mutations or by Administering a Thrombospondin-Derived Peptide. Cancer Res.
67: 440-444
[Abstract]
[Full Text]
-
Kim, B., Sarangi, P. P., Lee, Y., Deshpande Kaistha, S., Lee, S., Rouse, B. T.
(2006). Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. J. Leukoc. Biol.
80: 1405-1415
[Abstract]
[Full Text]
-
Kim, B., Suvas, S., Sarangi, P. P., Lee, S., Reisfeld, R. A., Rouse, B. T.
(2006). Vascular Endothelial Growth Factor Receptor 2-Based DNA Immunization Delays Development of Herpetic Stromal Keratitis by Antiangiogenic Effects. J. Immunol.
177: 4122-4131
[Abstract]
[Full Text]
-
Carr, D. J. J., Ash, J., Lane, T. E., Kuziel, W. A.
(2006). Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1.. J. Gen. Virol.
87: 489-499
[Abstract]
[Full Text]
-
Nakayama, T., Mutsuga, N., Yao, L., Tosato, G.
(2006). Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J. Leukoc. Biol.
79: 95-104
[Abstract]
[Full Text]
-
Kim, B., Lee, S., Suvas, S., Rouse, B. T.
(2005). Application of Plasmid DNA Encoding IL-18 Diminishes Development of Herpetic Stromal Keratitis by Antiangiogenic Effects. J. Immunol.
175: 509-516
[Abstract]
[Full Text]
-
Reinhardt, B., Schaarschmidt, P., Bossert, A., Luske, A., Finkenzeller, G., Mertens, T., Michel, D.
(2005). Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus. J. Gen. Virol.
86: 23-30
[Abstract]
[Full Text]
-
Kim, B., Tang, Q., Biswas, P. S., Xu, J., Schiffelers, R. M., Xie, F. Y., Ansari, A. M., Scaria, P. V., Woodle, M. C., Lu, P., Rouse, B. T.
(2004). Inhibition of Ocular Angiogenesis by siRNA Targeting Vascular Endothelial Growth Factor Pathway Genes: Therapeutic Strategy for Herpetic Stromal Keratitis. Am. J. Pathol.
165: 2177-2185
[Abstract]
[Full Text]
-
Biswas, P. S., Banerjee, K., Zheng, M., Rouse, B. T.
(2004). Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J. Leukoc. Biol.
76: 868-875
[Abstract]
[Full Text]
-
Ferrara, N.
(2004). Vascular Endothelial Growth Factor: Basic Science and Clinical Progress. Endocr. Rev.
25: 581-611
[Abstract]
[Full Text]
-
Biswas, P. S., Banerjee, K., Kim, B., Rouse, B. T.
(2004). Mice Transgenic for IL-1 Receptor Antagonist Protein Are Resistant to Herpetic Stromal Keratitis: Possible Role for IL-1 in Herpetic Stromal Keratitis Pathogenesis. J. Immunol.
172: 3736-3744
[Abstract]
[Full Text]
-
Banerjee, K., Biswas, P. S., Kim, B., Lee, S., Rouse, B. T.
(2004). CXCR2-/- Mice Show Enhanced Susceptibility to Herpetic Stromal Keratitis: A Role for IL-6-Induced Neovascularization. J. Immunol.
172: 1237-1245
[Abstract]
[Full Text]
-
Lundberg, P., Welander, P., Han, X., Cantin, E.
(2003). Herpes Simplex Virus Type 1 DNA Is Immunostimulatory In Vitro and In Vivo. J. Virol.
77: 11158-11169
[Abstract]
[Full Text]
-
Carr, D. J. J., Chodosh, J., Ash, J., Lane, T. E.
(2003). Effect of Anti-CXCL10 Monoclonal Antibody on Herpes Simplex Virus Type 1 Keratitis and Retinal Infection. J. Virol.
77: 10037-10046
[Abstract]
[Full Text]
-
Zheng, M., Klinman, D. M., Gierynska, M., Rouse, B. T.
(2002). DNA containing CpG motifs induces angiogenesis. Proc. Natl. Acad. Sci. USA
99: 8944-8949
[Abstract]
[Full Text]